Back
Recursion Pharmaceuticals Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
37
RXRX
Recursion Pharmaceuticals
Last Price:
$7.26
Seasonality Move:
-18.3%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.73 | Buy |
| 20-day SMA: | 6.94 | Buy |
| 50-day SMA: | 6.77 | Buy |
| 200-day SMA: | 7.78 | Sell |
| 8-day EMA: | 6.71 | Buy |
| 20-day EMA: | 6.83 | Buy |
| 50-day EMA: | 6.82 | Buy |
| 200-day EMA: | 7.54 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 51.49 | Buy |
| Chaikin Money Flow: | 19655122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.03 - 7.47) | Buy |
| Bollinger Bands (100): | (6.19 - 7.27) | Buy |
Recursion Pharmaceuticals Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 6.99 while RXRX 8-day simple moving average is 6.73, which is a Buy signal.
-
The stock price of RXRX is 6.99 while Recursion Pharmaceuticals 20-day SMA is 6.94, which makes it a Buy.
-
Recursion Pharmaceuticals 50-day simple moving average is 6.77 while RXRX share price is 6.99, making it a Buy technically.
-
RXRX stock price is 6.99 and Recursion Pharmaceuticals 200-day simple moving average is 7.78, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
37
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a SellThe current Recursion Pharmaceuticals [RXRX] share price is $6.99. The Score for RXRX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2B
Price in USD:
6.99
Share Volume:
20.6M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
5.60
Sell
37
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?The Recursion Pharmaceuticals stock price is 6.99 USD today.
-
Will RXRX stock go up or go down?Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Recursion Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
-
Recursion Pharmaceuticals share price is 6.99 while RXRX 8-day exponential moving average is 6.71, which is a Buy signal.
-
The stock price of RXRX is 6.99 while Recursion Pharmaceuticals 20-day EMA is 6.83, which makes it a Buy.
-
Recursion Pharmaceuticals 50-day exponential moving average is 6.82 while RXRX share price is 6.99, making it a Buy technically.
-
RXRX stock price is 6.99 and Recursion Pharmaceuticals 200-day simple moving average is 7.54, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
-
RXRX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Recursion Pharmaceuticals is a Sell
-
Recursion Pharmaceuticals Relative Strength Index (RSI) is 51.49, which suggest Recursion Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Recursion Pharmaceuticals is (6.03 - 7.47), which suggest Recursion Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.19 - 7.27), which suggest Recursion Pharmaceuticals is a Buy
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.